A watercolor painting of blue Hydrangeas with a tan postcard like background.

Subscription and open access journals from Sage, the world's leading independent academic publisher.

ALT: A pencil sketch of Twenty Young Girls in a Group Walking to the Left by Thomas Stothard (English, 1755-1834).

ALT: The Drawing "Alarming Case of Indigestion: The Doctor Called In" (1847) by John Doyle (Irish, 1797 – 1868), showing a man in a seat surrounded by others, including a doctor sat in front of him.

Start date: Wednesday 7 October 2026End date: Wednesday 14 October 2026

Why Calling Yourself a “Self-Taught Artist” Is less attractive than you think and why studying art is worth the effort.

ALT: Country Life Stories: Some Rural Community Helpers page illustration 11 (1938) by Vernon Winslow (American, 20th Century), a painting of a woman and child looking into a delivery van with a man to their left assisting them.

ALT: A dimly lit painting depicting a group of individuals gathered around a long table, illuminated by a central light source. The scene takes place under an open, arched structure with a view of a serene, twilight landscape in the background. The figures appear engaged in discussion or contemplation, with a warm, subdued atmosphere dominating the artwork.

ALT: A Drawing of Cibotium regale, an almost alien-esque fern with green leaves and an orange body.

Randomized controlled trials (RCTs) are regarded as the highest level of evidence in medical research, but RCTs also have their drawbacks. Over the years, several alternative study designs have been i...

Background The use of estimands in clinical trials was formalised with the adoption of the final International Conference on Harmonisation E9 Addendum on Estimands and Sensitivity Analysis in Clinical Trials (ICH E9(R1) Addendum) in November 2019. The declared objective of the ICH E9(R1) Addendum is to bring clarity and transparency to the research question of interest. For this to be achieved, the estimand must be described in accordance with the requirements of the ICH E9(R1) Addendum so that the target treatment effect is clear to all stakeholders. Previous reviews of publications and published protocols have found that few trials explicitly defined the primary estimand. To obtain a more complete picture of how the use of estimands has changed over time, whether trials are using estimands correctly (i.e. correctly defining the five attributes of an estimand), and which strategies are being used to handle intercurrent events, we obtained access to an extensive database of original research protocols (n = 29,212) submitted to the United Kingdom’s Health Research Authority, which oversees ethical review of clinical trials. Methods Protocols were eligible for review if they included the term ‘estimand’ and attempted to define at least one attribute of the primary estimand. For eligible protocols, we extracted information on trial characteristics such as whether the trial was randomized and the therapeutic area, as well as whether the estimand attributes used for the primary outcome were correctly defined, and which strategies were used to handle intercurrent events. Results We found that the number of protocols defining a primary estimand increased starkly with publication of the ICH E9(R1) Addendum (approximately 3 protocols/year pre-ICH E9(R1) Addendum vs. 18 protocols / year during the consultation period vs. 23 protocols in the year following the adoption of the ICH E9(R1) Addendum). However, the description of the primary estimand was suboptimal; many protocols failed to mention specific attributes (such as population or treatment conditions) in the estimand description, and many protocols incorrectly defined estimand attributes (e.g. by describing the estimand population based on their analysis population). Conclusions Although release of the ICH E9(R1) Addendum has dramatically increased the use of estimands in clinical trials, their reporting is suboptimal. There is still work to be done to ensure estimands reach their full potential in bringing clarity and focus to research questions.